(A) Morphological analysis of IBA1+ cells in the cerebellar cortex
of Cb1a6– and control mice (n = 4–5
per group, 6 cells per mouse). Scale bar: 25 μm. *P < 0.05,
***P < 0.001 versus control. (B) Analysis of
Cb2r mRNA expression by qRT-PCR and inflammation-related genes in the
cerebellum of Cb1a6– and control mice (n =
5 per group). *P < 0.05 versus control. (C) Flow cytometric
analysis of CD11b expression and qRT-PCR analysis of Cb1r,
Cb2r, and Il1b of acutely dissociated cerebellar cells from
Cb1a6– and control mice (n = 3–4
per group). *P < 0.05 versus control. (D) Immunoblot
detection and quantification of ARC/ARG3.1 in cerebellar homogenates from
Cb1a6– and control mice (n = 5–6
mice per group). *P < 0.05 versus control. (E) ARC/ARG3.1
immunostaining in Cb1a6– and control mice. Plot represents
ARC/ARG3.1 intensity along the cerebellar layers. Scale bar: 100 μm. (F)
Motor coordination analysis of Cb1a6– and control mice
(n = 11–15 per group). (G) Motor coordination analysis
with the coat-hanger test in Cb1a6– and control mice
(n = 8–10 per group). Four hours before the test, the mice received
an injection of IL-1RA (100 mg/kg, i.p.) or its VEH (DMSO). *P < 0.05,
**P < 0.01, ***P < 0.001 versus control.
#P < 0.05 versus Cb1a6–
plus DMSO.